Drug
Adx 038
Adx 038: highest development phase Phase 2, developed by ADARx Pharmaceuticals, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- ADARx Pharmaceuticals, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| ADX-038 NCT06990269 | Phase 2 | Geographic Atrophy Secondary to Age-related Macular Degeneration |
Latest
No recent events.
Follow Adx 038 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.